文献速递银屑病与炎症性皮肤病湿疹皮炎与荨麻疹皮肤肿瘤

肤色皮肤病的遗传学、生物学和表型差异——第一部分:肤色皮肤在遗传、生物学和结构上的差异

Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color - Part I: Genetic, biologic, and structural differences in skin of color.
PubMed 文献 · J Am Acad Dermatol · 2022-07-06

本文综述肤色人群(SOC)中炎症性皮肤病(特应性皮炎、银屑病、化脓性汗腺炎)和恶性肿瘤(黑色素瘤、基底细胞癌、皮肤T细胞淋巴瘤)在免疫表型上的差异,强调健康社会决定因素对健康不平等的作用常大于归因于「种族」的生物学或遗传因素,并呼吁开展更多大规模稳健的遗传学研究以开发针对性疗法。

要点

  • 肤色人群涵盖黑人/非洲裔、西班牙裔/拉丁裔、亚裔/太平洋岛民、美洲印第安人/阿拉斯加原住民、澳大利亚原住民、中东裔、混血/多民族或非白人群体,列表不穷尽且随文化而异。
  • 近期遗传和免疫学研究提示,特应性皮炎、银屑病、化脓性汗腺炎及黑色素瘤、基底细胞癌、皮肤T细胞淋巴瘤在肤色人群中可能存在免疫表型差异。
  • 健康社会决定因素在驱动肤色人群健康不平等中的作用常大于归因于「种族」的生物学或遗传因素,理解这一点至关重要。

核心结论

  • 肤色人群的炎症性皮肤病和恶性肿瘤可能存在免疫表型差异,健康社会决定因素常比归因于「种族」的生物学或遗传因素在医疗结局中起更大作用。
  • 本文强调需要增加对肤色人群皮肤病的大规模、稳健的遗传学研究,以为这一常被忽视和研究不足的人群开发更有针对性、更有效的疗法。

研究设计与样本

  • 本文为综述,检索范围未在原文中报告。

主要发现

  • 近期遗传和免疫学研究提示,特应性皮炎、银屑病和化脓性汗腺炎以及黑色素瘤、基底细胞癌和皮肤T细胞淋巴瘤在肤色人群中可能存在免疫表型变异。
  • 健康社会决定因素在驱动肤色人群健康不平等中起重要作用,且常比归因于「种族」的生物学或遗传因素在医疗结局中起更大作用。

临床怎么用

  • 本文强调增加对肤色人群皮肤病的大规模、稳健的遗传学研究,以开发更有针对性、更有效的疗法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Skin of color (SOC) populations include those who identify as Black/African, Hispanic/Latinx, Asian/Pacific Islander, American Indian/Native Alaskan, Indigenous Australian, Middle Eastern, biracial/multiracial, or non-White; this list is far from exhaustive and may vary between and within cultures. Recent genetic and immunological studies have suggested that cutaneous inflammatory disorders (atopic dermatitis, psoriasis, and hidradenitis suppurativa) and malignancies (melanoma, basal cell carcinoma, and cutaneous T-cell lymphoma) may have variations in their immunophenotype among SOC. Additionally, there is growing recognition of the substantial role social determinants of health play in driving health inequalities in SOC communities. It is critically important to understand that social determinants of health often play a larger role than biologic or genetic factors attributed to "race" in health care outcomes. Herein, we describe the structural, genetic, and immunological variations and the potential implications of these variations in populations with SOC. This article underscores the importance of increasing the number of large, robust genetic studies of cutaneous disorders in SOC to create more targeted, effective therapies for this often underserved and understudied population. Part II of this CME will highlight the clinical differences in the phenotypic presentation of and the health disparities associated with the aforementioned cutaneous disorders in SOC.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Brown-Korsah JB, McKenzie S, Omar D, et al. Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color - Part I: Genetic, biologic, and structural differences in skin of color. J Am Acad Dermatol. 2022. PMID: 35809800. doi:10.1016/j.jaad.2022.06.1193

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。